Taiwan S.E.
06:00:00 2024-04-25 pm EDT
5-day change
1st Jan Change
25.95
TWD
+6.35%
+8.81%
+3.39%
OK Biotech Co., Ltd. acquired unknown minority stake in Prodigy Diabetes Care, LLC.
April 16, 2013 at 12:00 am EDT
OK Biotech Co., Ltd. (GTSM:4155) acquired unknown minority stake in Prodigy Diabetes Care, LLC on April 16, 2013. In a related deal, Prodigy Diabetes Care acquired a substantial ownership of publicly traded shares of OK Biotech.
OK Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 18
CI
Ok Biotech Co., Ltd. Resolved to Approve cash Dividend Distribution for January 1, 2023 to December 31, 2023
Mar. 12
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 13
CI
OK Biotech Co., Ltd.(TWSE:4155) added to S&P Global BMI Index
23-09-18
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-13
CI
OK Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-15
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-28
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-13
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-08-11
CI
OK Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-11
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22-03-31
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-11
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
21-08-16
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
21-05-13
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
21-03-30
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
20-11-11
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
20-08-12
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
20-05-12
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
20-03-23
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
19-11-12
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
19-08-13
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019
19-05-13
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
19-03-27
CI
OK Biotech Co., Ltd.(GTSM:4155) added to Taiwan TAIEX Index
18-03-14
CI
OK Biotech Co., Ltd. acquired unknown minority stake in Prodigy Diabetes Care, LLC.
13-04-16
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
More about the company
1st Jan change
Capi.
+3.39% 116M +73.17% 12.38B -18.74% 7.92B +16.15% 7.2B +4.81% 5.84B +5.99% 5.01B +27.07% 4.53B -21.67% 3.88B -40.82% 2.23B +1.49% 2.02B
Medical Equipment
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
OK BIOTECH CO., LTD. 
